Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2024-02-14 | LEIDEN JEFFREY M | Executive Chairman | Sell | 4,356 | $419.04 | $1,825,338.24 | -16.2% | → |
| 2024-02-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 3,393 | $419.42 | $1,423,104.12 | -3.9% | → |
| 2024-02-12 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 314 | $420.24 | $131,955.36 | -0.5% | → |
| 2024-02-12 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | 913 | $420.24 | $383,679.12 | -3.8% | → |
| 2024-02-12 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 3,145 | $420.24 | $1,321,654.80 | -6.2% | → |
| 2024-02-12 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 1,374 | $420.24 | $577,409.76 | -12.4% | → |
| 2024-02-12 | Arbuckle Stuart A | EVP, COO | Sell | 4,295 | $420.24 | $1,804,930.80 | -5.4% | → |
| 2024-02-12 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 1,738 | $418.77 | $727,822.26 | -8.7% | → |
| 2024-02-12 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 3,222 | $420.24 | $1,354,013.28 | -4.2% | → |
| 2024-01-08 | LEIDEN JEFFREY M | Executive Chairman | Sell | 6,648 | $419.07 | $2,785,977.36 | -73.3% | → |
| 2024-01-02 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3,000 | $405.00 | $1,215,000.00 | -6.4% | → |
| 2023-12-15 | Kewalramani Reshma | CEO & President | Sale+OE | 17,135 | $407.00 | $6,973,945.00 | -13.6% | → |
| 2023-12-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 13,354 | $399.42 | $5,333,799.14 | -42.3% | → |
| 2023-12-13 | Arbuckle Stuart A | EVP, COO | Sale+OE | 8,603 | $399.00 | $3,432,597.00 | -13.2% | → |
| 2023-12-13 | Kewalramani Reshma | CEO & President | Sell | 5,098 | $397.00 | $2,023,906.00 | -4.5% | → |
| 2023-11-20 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Sell | 3,000 | $349.88 | $1,049,640.00 | -6.0% | → |
| 2023-11-15 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | 35 | $369.92 | $12,947.20 | - | → |
| 2023-11-15 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 19 | $369.92 | $7,028.48 | - | → |
| 2023-11-14 | Bozic Carmen | EVP and CMO | Sell | 5,650 | $380.82 | $2,151,633.00 | -16.2% | → |
| 2023-11-13 | Kewalramani Reshma | CEO & President | Sell | 5,097 | $377.00 | $1,921,569.00 | -4.3% | → |
| 2023-11-06 | SACHS BRUCE I | Director | Sale+OE | 11,250 | $385.00 | $4,331,250.00 | -22.0% | → |
| 2023-10-31 | Bozic Carmen | EVP and CMO | Sell | 5,651 | $355.92 | $2,011,303.92 | -13.9% | → |
| 2023-10-17 | Bozic Carmen | EVP and CMO | Sell | 5,651 | $373.25 | $2,109,235.75 | -12.2% | → |
| 2023-10-17 | Bhatia Sangeeta N. | Director | Sell | 243 | $375.00 | $91,125.00 | -5.9% | → |
| 2023-10-16 | LEIDEN JEFFREY M | Executive Chairman | Sell | 12,962 | $374.00 | $4,847,788.00 | -36.6% | → |
| 2023-10-06 | Bhatia Sangeeta N. | Director | Sell | 242 | $360.00 | $87,120.00 | -5.5% | → |
| 2023-10-03 | Bozic Carmen | EVP and CMO | Sell | 5,651 | $345.28 | $1,951,177.28 | -10.9% | → |
| 2023-10-02 | Biller Jonathan | EVP and Chief Legal Officer | Sell | 610 | $346.76 | $211,523.60 | -5.5% | → |
| 2023-09-19 | Bozic Carmen | EVP and CMO | Sell | 5,651 | $351.00 | $1,983,501.00 | -9.8% | → |
| 2023-09-05 | Bozic Carmen | EVP and CMO | Sell | 5,651 | $352.66 | $1,992,881.66 | -8.9% | → |
| 2023-08-23 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 2,500 | $355.00 | $887,500.00 | -4.9% | → |
| 2023-08-10 | Kearney Terrence C | Director | Sale+OE | 10,000 | $350.00 | $3,500,000.00 | -60.5% | → |
| 2023-08-10 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 10,031 | $350.00 | $3,510,850.00 | -14.6% | → |
| 2023-08-10 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 5,750 | $345.79 | $1,988,292.50 | -10.1% | → |
| 2023-08-09 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 63 | $345.51 | $21,767.13 | -0.2% | → |
| 2023-08-09 | Bhatia Sangeeta N. | Director | Sell | 242 | $345.51 | $83,613.42 | -5.2% | → |
| 2023-07-17 | Kewalramani Reshma | CEO & President | Sell | 7,828 | $355.00 | $2,778,940.00 | -6.2% | → |
| 2023-07-17 | SACHS BRUCE I | Director | Sale+OE | 11,250 | $356.75 | $4,013,458.81 | -7.8% | → |
| 2023-06-15 | Arbuckle Stuart A | EVP, COO | Sale+OE | 8,603 | $349.00 | $3,002,447.00 | -13.2% | → |
| 2023-05-30 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 289 | $329.82 | $95,317.98 | -4.1% | → |
| 2023-05-30 | Arbuckle Stuart A | EVP, COO | Sell | 82 | $329.82 | $27,045.24 | -0.1% | → |
| 2023-05-08 | LEIDEN JEFFREY M | Executive Chairman | Sell | 2,004 | $349.25 | $699,887.34 | -1.8% | → |
| 2023-05-08 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 2,850 | $350.00 | $997,500.00 | -8.2% | → |